Chicago, ILNCT06008860Now EnrollingIRB Ready

COVID-19 Clinical Trial in Chicago, IL

Access cutting-edge covid-19 treatment through this phase 4 clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Chicago

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access covid-19 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related covid-19 treatment provided free

Apply for This Chicago Location

Check if you qualify for this covid-19 clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This COVID-19 Study in Chicago

The study team proposes to evaluate the efficacy of Astepro® 0.15% nasal spray in treating SARS-CoV-2 infection in adults through a pilot and feasibility clinical trial at the University of Chicago.

Sponsor: University of Chicago

Who Can Participate

Inclusion Criteria

(Primary Cohort):
Ability to consent
Have a Covid-19 positive saliva sample prior to the start of treatment; or positive rapid antigen test at home confirmed via first COVID-19 positive saliva sample
Ability to follow the study instructions and adhere to the study procedures
Ability to provide every other day saliva samples throughout the study period 10 days, and report symptoms
Subjects that have been vaccinated for Covid-19
Does not have any symptoms or only experiencing mild symptoms of Covid-19 (e.g., such as fever below a threshold or no fever, or without severe cough, among others). Inclusion Criteria (Close Contacts):
Ability to consent
Ability to follow the study instructions and report side effects
Ability to provide saliva samples throughout the study period
Subjects that have been vaccinated for Covid-19.

Exclusion Criteria

(Primary Cohort):
Women who are breastfeeding, pregnant, or who plan to become pregnant
Contradictions to intranasal azelastine (known hypersensitivity)
Use of other Covid-19 treatments (steroids, convalescent plasma, therapeutic antibodies, etc.)
Intranasal, corticosteroid, immunomodulator, or other medication use which can change the effect of Astepro.
Prior Covid infection greater than 5 and less than 30 days before enrollment
Subjects who have been involved with any other research study within the last 30 days.
A prior hypersensitivity to olopatadine (Patanase), diphenhydramine, hydroxyzine. Subjects that have not been vaccinated for Covid-19. Subjects that have moderate to severe COVID-19 symptoms, or signs of meeting indications (e.g. Shortness of Breath, chest pains) for urgent or emergent therapy (these subjects will be advised to seek emergency medical assistance). Exclusion Criteria (Close Contacts)
Prior Covid infection less than 30 days or greater 5 days prior to enrollment in study
Use of other Covid-19 treatments
Having a positive rapid home or PCR COVID test prior to the positive test for the primary cohort subject they're associated with
Involved with any other research study within the last 30 days
Subjects that have not been vaccinated for Covid-19.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT06008860) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

COVID-19 Treatment Options in Chicago, IL

If you're searching for covid-19 treatment options in Chicago, IL, this clinical trial (NCT06008860) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all covid-19 clinical trials near you to find additional studies recruiting in your area.

More COVID-19 Trials in Chicago, IL

See all covid-19 clinical trials recruiting in Chicago — not just this study.

Browse COVID-19 Trials in Chicago →

Browse More Trials by Condition

COVID-19 TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL